Effect of prenatal phthalate exposure on fetal development and maternal/neonatal health consequences: A systematic

Laura Almeida-Toledano1, Elisabet Navarro-Tapia2, Giorgia Sebastiani3

  • 1Institut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain; BCNatal, Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, Universitat de Barcelona, 08950 Barcelona, Spain.

Insights

Prenatal exposure to phthalates, common in plastics and personal care items, is linked to pregnancy complications and neurodevelopmental issues in children. Further research is needed to understand specific mechanisms and safe exposure levels.

Area of Science:

  • Environmental Health
  • Reproductive Toxicology
  • Developmental Pediatrics

Background:

  • Phthalates are widespread in consumer products, leading to significant human exposure.
  • Prenatal exposure to phthalates is a growing concern due to potential adverse effects on maternal and fetal health.
  • Existing research indicates a link between phthalate exposure and various health issues, necessitating a comprehensive review.

Purpose of the Study:

  • To systematically review the impact of prenatal phthalate exposure on major pregnancy complications.
  • To analyze the role of phthalates in fetal neurodevelopmental disorders.
  • To discuss molecular mechanisms and critical exposure windows for phthalate-induced effects.

Main Methods:

  • Systematic literature review adhering to PRISMA methodology.
  • Inclusion of over 100 articles published within the last 10 years.
  • Analysis of studies investigating phthalate exposure and pregnancy outcomes/fetal development.

Main Results:

  • Maternal exposure to phthalates is associated with an increased risk of gestational diabetes, pregnancy-induced hypertension, fetal growth restriction, and preterm birth.
  • Prenatal phthalate exposure negatively impacts children's motor skills, memory, and language acquisition, and increases risks for autism spectrum disorder traits and ADHD.
  • Di(2-ethylhexyl) phthalate and its metabolites are frequently implicated in these adverse outcomes.

Conclusions:

  • Prenatal phthalate exposure poses significant risks to pregnancy and fetal neurodevelopment.
  • Endocrine disruption, oxidative stress, inflammation, and DNA methylation are key molecular mechanisms involved.
  • The first trimester is a critical window for exposure, highlighting the need for further research into specific effects and long-term consequences.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
962
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
259